S
QTTB icon

Sanofi’s Q32 Bio QTTB Stock Holding History

Sanofi’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.11M Hold
244,083
– – 0.58% 10
2026
Q1 		$1.57M Hold
244,083
– – 0.47% 9
2025
Q4 		$810K Hold
244,083
– – 0.26% 8
2025
Q3 		$483K Hold
244,083
– – 0.19% 9
2025
Q2 		$364K Hold
244,083
– – 0.21% 10
2025
Q1 		$403K Hold
244,083
– – 0.24% 9
2024
Q4 		$840K Buy
+244,083
New +$7.71M 0.48% 9

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi's QTTB Position: Q2 2026 in Review

Sanofi held its Q32 Bio (QTTB) position steady in Q2 2026 at 244,083 shares worth $3.11M. The position accounts for 0.58% of the portfolio, ranked #10.

Sanofi first reported a position in QTTB in Q4 2024 and has held it in 7 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Sanofi held 244,083 shares of Q32 Bio worth $3.11M as of Q2 2026.
  • Sanofi left its Q32 Bio share count unchanged in Q2 2026.
  • Q32 Bio made up 0.58% of Sanofi's portfolio in Q2 2026, its #10 holding.
  • Sanofi first reported a position in Q32 Bio in Q4 2024 and has held it in 7 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Sanofi's 13F filing for Q2 2026, filed 28 Jul 2026.